Results 151 to 160 of about 10,981,913 (333)

Respect action plan [PDF]

, 2006

core  

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

Temperature-Related Health Impacts: A Scoping Review and Benchmarking Exercise to Inform a Heat Action Plan. [PDF]

Ann Glob Health
Wright CY, Bulani M, Kapwata T, Dikoko V, Naidoo N.   +4 more
europepmc   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Alberta Family Caregiver Strategy and Action Plan: Enhancing Integration Across Health and Social Care Systems. [PDF]

Int J Environ Res Public Health
Parmar J, Ewa V, Karesa A, Grewal A, Charles L, Powell L, Amelio J, Bitzer G, Saunders S, Schindel D, Shapkin K, Pooler C, Ross F, Sonnema L, Jowhari S, Grinman MN, Cameron C, Huhn A, Murphy P, Lowther J, Sim C, Brémault-Phillips S, Anderson S.   +22 more
europepmc   +1 more source

Young runaways action plan [PDF]

, 2008

core  

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Be-SNAP: the Belgian Sepsis National Action Plan. [PDF]

Front Public Health
Mondelaers A, Van de Voorde F, Peperstraete H, Dewitte K, De Waele J, Malfait I, Van de Voorde P, Vlieghe E.   +7 more
europepmc   +1 more source

UK-Czech action plan 2001 [PDF]

, 2001
-
core  

action plan [PDF]

, 2016
azizkhani, nooroozali
core   +1 more source